Comparison of effects of Y-27632 and Isoproterenol on release of cytokines from human peripheral T cells

International Immunopharmacology

Volumn 3, Issue 12, 2003, Pages 1619-1625

  Aihara, Masayuki ^a   Dobashi, Kunio ^a   Iizuka, Kunihiko ^a   Nakazawa, Tsugio ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Concanavalin A; Cytokines; Human T cells; Isoproterenol; Y 27632

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CONCANAVALIN A; ISOPRENALINE; RHO KINASE; T LYMPHOCYTE RECEPTOR;

ARTICLE; CELL STIMULATION; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INCUBATION TIME; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; MOLECULAR MIMICRY; NORMAL HUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

EID: 0141526318     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00184-X     Document Type: Article

References (30)

1. Cantrell D.A. GTPases and T cell activation. Immunol. Rev. 192:2003;122-130.
2. Uehata M., Ishizaki T., Satoh H., Ono T., Kawahara T. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 389:1997;990-994.
3. Ishizaki T., Uehata M., Tamechika I., Keel J., Nonomura K.et al. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol. Pharmacol. 57:2000;976-983.
4. Kawaguchi A., Ohmori M., Harada K., Tsuruoka S., Sugimoto K.et al. The effect of a rho kinase inhibitor Y-27632 on superoxide production, aggregation and adhesion in human polymorphonuclear leukocytes. Eur. J. Pharmacol. 403:2000;203-208.
5. Lou Z., Billadeau D.D., Savoy D.N., Schoon R.A., Leibson P.J. A role for a RhoA/ROCK/LIM-kinase pathway in the regulation of cytotoxic lymphocytes. J. Immunol. 167:2001;5749-5757.
6. Yoshii A., Iizuka K., Dobashi K., Horie T., Harada T.et al. Relaxation of contracted rabbit tracheal and human bronchial smooth muscle by Y-27632 through inhibition of Ca2+ sensitization. Am. J. Respir. Cell Mol. Biol. 20:1999;1190-1200.
7. Essler M., Staddon J.M., Weber P.C., Aepfelbacher M. AMP Cyclic blocks bacterial lipopolysaccharide-induced myosin light chain phosphorylation in endothelial cells through inhibition of Rho/Rho kinase signaling. J. Immunol. 164:2000;6543-6549.
8. Lang P., Gesbert F., Delespine-Carmagnat M., Stancou R., Pouchelet M.et al. Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J. 15:1996;510-519.
9. Iizuka K., Shimizu Y., Tsukagoshi H., Yoshii A., Harada T.et al. Evaluation of Y-27632, a rho-kinase inhibitor, as a bronchodilator in guinea pigs. Eur. J. Pharmacol. 406:2000;273-279.
10. Aihara M., Dobashi K., Horie T., Araki T., Yoshii A.et al. Effect of beta-agonists on production of cytokines by activated T cells obtained from asthmatic patients and normal subjects. J. Asthma. 36:1999;619-626.
11. Heumann D., Vischer T.L. Activation of resting T lymphocytes by cross-linked anti-CD3 (T3). Eur. J. Immunol. 17:1987;1657-1660.
12. Marinissen M.J., Chiariello M., Gutkind J.S. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38gamma) MAP kinase pathway. Genes Dev. 15:2001;535-553.
13. Cao Y., Janssen E.M., Duncan A.W., Altman A., Billadeau D.D.et al. Pleiotropic defects in TCR signaling in a Vav-1-null Jurkat T-cell line. EMBO J. 21:2002;4809-4819.
14. Charvet C., Auberger P., Tartare-Deckert S., Bernard A., Deckert M. Vav1 couples T cell receptor to serum response factor-dependent transcription via a MEK-dependent pathway. J. Biol. Chem. 277:2002;15376-15384.
15. Schafer P.H., Wadsworth S.A., Wang L., Siekierka J.J. p38 alpha mitogen-activated protein kinase is activated by CD28-mediated signaling and is required for IL-4 production by human CD4+CD45RO+ T cells and Th2 effector cells. J. Immunol. 162:1999;7110-7119.
16. Koprak S., Staruch M.J., Dumont F.J. A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: dependence on CD28 signaling and preferential inhibition of IL-10 production. Cell. Immunol. 192:1999;87-95.
17. Woodside D.G., Wooten D.K., McIntyre B.W. Adenosine diphosphate (ADP)-ribosylation of the guanosine triphosphatase (GTPase) rho in resting peripheral blood human T lymphocytes results in pseudopodial extension and the inhibition of T cell activation. J. Exp. Med. 188:1998;1211-1221.
18. Angkachatchai V., Finkel T.H. ADP-ribosylation of rho by C3 ribosyltransferase inhibits IL-2 production and sustained calcium influx in activated T cells. J. Immunol. 163:1999;3819-3825.
19. Costello P.S., Walters A.E., Mee P.J., Turner M., Reynolds L.F.et al. The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways. Proc. Natl. Acad. Sci. U. S. A. 96:1999;3035-3040.
20. Gulbranson Judge A., Tybulewicz V.L., Walters A.E., Toellner K.M., MacLennan I.C.et al. Defective immunoglobulin class switching in Vav-deficient mice is attributable to compromised T cell help. Eur. J. Immunol. 29:1999;477-487.
21. Janssen L.J., Premji M., Netherton S., Coruzzi J., Lu-Chao H.et al. Vasoconstrictor actions of isoprostanes via tyrosine kinase and Rho kinase in human and canine pulmonary vascular smooth muscles. Br. J. Pharmacol. 132:2001;127-134.
22. Sullivan R., Price L.S., Koffer A. Rho controls cortical F-actin disassembly in addition to, but independently of secretion in mast cells. J. Biol. Chem. 274:1999;38140-38146.
23. Tordai A., Sarkadi B., Gorog G., Gardos G. Inhibition of the CD3-mediated calcium signal by protein kinase C activators in human T (Jurkat) lymphoblastoid cells. Immunol. Lett. 20:1989;47-52.
24. Aihara M., Dobashi K., Horie T., Iizuka K., Nakazawa T.et al. Effects of isoproterenol on IL-2 and cAMP production in peripheral T cells from asthmatic and non-asthmatic subjects sensitive to Candida. Biol. Cell. 91:1999;525-531.
25. Borger P., Jonker G.J., Vellenga E., Postma D.S., De Monchy J.G.et al. Allergen challenge primes for IL-5 mRNA production and abrogates beta-adrenergic function in peripheral blood T lymphocytes from asthmatics. Clin. Exp. Allergy. 29:1999;933-940.
26. Staples K.J., Bergmann M., Tomita K., Houslay M.D., McPhee I.et al. Adenosine 3′,5′-cyclic monophosphate (cAMP)-dependent inhibition of IL-5 from human T lymphocytes is not mediated by the cAMP-dependent protein kinase A. J. Immunol. 167:2001;2074-2080.
27. Borger P., Kauffman H.F., Postma D.S., Vellenga E. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway. Blood. 87:1996;691-698.
28. Borger P., Vellenga E., Gringhuis S.I., Timmerman J.A., Lummen C.et al. Prostaglandin E2 differentially modulates IL-5 gene expression in activated human T lymphocytes depending on the costimulatory signal. J. Allergy Clin. Immunol. 101:1998;231-240.
29. Laudanna C., Campbell J.J., Butcher E.C. Elevation of intracellular cAMP inhibits RhoA activation and integrin-dependent leukocyte adhesion induced by chemoattractants. J. Biol. Chem. 272:1997;24141-24144.
30. Dong J.M., Leung T., Manser E., Lim L. cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROKalpha. J. Biol. Chem. 273:1998;22554-22562.